Message Font: Serif | Sans-Serif
 
No. of Recommendations: 1
https://boards.fool.com/blueprint-34188772.aspx


So ….

avapritinib
D482V: 350m
GIST: 3.5b** (will come in stepwise fashion)
mastocytosis: 525m

TOTAL: 4.375

667:
NSCLC: 700m (competing with LOXO)

554:
HCC: 5.25b (competing with LOXO)

782:
?


total addressable market: 10.325b
total addressable market by year end 2020: ~5b

Current market cap: 3.5b


Do the drugs work?
Ava – yes
667 – yes, but lets see how part two of ARROW goes
554- dont know
782- dont know


continued...
Print the post  

Announcements

What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.